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THE stimulation of bone resorption by parathyroid hormone can be quan- 
titated in tissue cultures of embryonic bone [20], using paired limb bones 
from a single embryo in which radioactive calcium (45Ca) has previously 
been incorporated. The ratio of 45Ca release from the parathyroid hormone- 
treated bones to that from the control bones is a sensitive measure of parathy- 
roid effect. This technique has been applied to a study of the mechanism 
of action of parathyroid hormone and of other factors affecting bone resorp- 
tion and also has been used to assay for parathyroid hormone activity in 
biological fluids [S, 21-231. The major disadvantages of this system are the 
variability of the response [al] and the difficulty in analyzing for small bio- 
chemical changes. Because our preliminary observations suggested that 
some of these disadvantages might be ascribable to the high concentration 
of serum (50 per cent) used in the culture medium, the objective of the present 
study was to find the simplest and chemically best defined medium in which 
bone resorption could be stimulated by parathyroid hormone. Chemically 
defined media without serum proved to be inadequate to support parathyroid 
hormone-induced bone resorption; therefore the minimum serum concentra- 
tion required for a parathyroid effect was determined and the constituent of 
serum necessary for this response identified. The critical factor occurs in the 
albumin fraction of serum. This fraction appears to contain a non-parathyroid 
factor which can both support parathyroid-stimulated bone resorption and 
enhance 45Ca release from control bones. 
1 Present address: Department of Pharmacology, Northwestern University Medical School, 
Chicago, Ill. 60611, U.S.A. 
Experimental Cell Research 46 
The role of serum in bone resorption 107 
METHODS 
Animals.-Details of the method have been published previously [21]. 17-day- 
pregnant Holtzman or Rochester-Wistar rats were injected subcutaneously with 
200-500 PC of 4SCaCl,. These rats were sacrificed two days later, the embryos removed 
and the bone shafts of paired radii and ulnae cultivated in individual vessels con- 
taining 0.5 ml of culture medium for 72 hr at 37°C either in an atmosphere of 5 per 
cent CO, in air, or in 5 per cent CO,, 75 per cent N, and 20 per cent 0,. 
Me&-Media used in the present study included (1) Eagle Basal Medium with 
Earle’s balanced salt solution, (2) Eagle Minimal Essential Medium with Earle’s 
balanced salt solution, (3) Trowel1 T-8 medium, without chloramphenicol, (4) Way- 
mouth MB 752/l, (5) McCoy 5A, (6) NCTC 109, and (7) 1066. The Trowel1 medium, 
which does not contain vitamins, was supplemented to bring the vitamin content 
equal to that in the Eagle media. In addition to the standard Waymouth MB 752/l, 
a modified preparation was tested. This modified medium contained an additional 
19 pgjml nicotinamide and 32.5 pug/ml ascorbic acid, and was also supplemented with 
1 @g/ml a-tocopherol and 0.5 mg/ml sodium acetate. These additions eliminated 
some major differences between the Waymouth MB 752/l and Biggers’ medium 
BGJ, a chemically defined medium reported to support development of embryonic 
bone rudiments in vitro [3]. Two different 1066 preparations were used: one (Difco 
T&Medium 1066) contained 0.1 g/l of a porcine liver coenzyme concentrate, whereas 
these same coenzymes were present in a more highly purified form at a total concen- 
tration of 0.01 g/l in the other preparation (CMRL 1066, Grand Island Biological 
Company, GIBCO). 
Sera.-Human serum was obtained from fasting laboratory personnel or purchased 
from commercial sources. Rat serum was obtained by cardiac puncture from animals 
that had been parathyroidectomized 1 month to 1 year previously (PTX rat serum), 
and was not used unless the calcium concentration was below 7.0 mg/lOO ml. 
Serum was heated at 56”-60°C for 30 min to inactivate complement. For preparation 
of dialysate and residual fractions, serum was dialyzed against CMRL 1066 for 48 hr 
at 4°C with Visking dialysis tubing. To determine the extent of calcium binding by 
albumin, equilibrium dialysis was performed under conditions simulating those used 
for incubation of the cultures (72 hr, 37” C, 5 per cent CO,). 
Hormones.--Two hormone preparations were used, (1) bovine parathyroid extract, 
PTE, Eli Lilly Company; control bones received an equal amount of the hormone 
solvent (1.6 per cent glycerol, 0.2 per cent phenol, 0.9 per cent NaCl) and (2) bovine 
parathyroid hormone (PTH) supplied by Dr W.Y.W. Au. The PTH had been purified 
by gel filtration [15] and had a potency of 2500 units/mg. It was dissolved in distilled 
water (40 /Lg/ml); distilled water was added to control bone cultures. 
Proteins.-Human and PTX rat serum albumins were prepared as described by 
Schwert [25]. This material has been shown to be chemically and biologically in- 
distinguishable from native albumin except for a small difference in the rate of 
trypsin hydrolysis [25, 261. The following bovine serum protein fractions (Pentex) 
were used: (1) bovine serum albumin, fraction V, reported to contain 90 per cent 
albumin contaminated with a- and ,&globulins, (2) a free fatty acid (FFA)-poor frac- 
tion V preparation containing less than 0.05 per cent fatty acid, (3) crystalline bovine 
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serum albumin, 100 per cent pure, (4) a-globulins, fraction IV, (5) p-globulins, frac- 
tion III and (6) y-globulins, fraction II. The non-serum proteins also tested included: 
(7) crystalline ovalbumin (Worthington), (8) calf thymus histone, B grade (Calbio- 
them), (9) gelatin, technical (Will Corp.), (10) insulin (Iletin@, Eli Lilly Co.) and (11) 
heparin (Heparin sodium, Nutritional Biochemicals Corp.). 
Assays.-Stable calcium concentrations were measured calorimetrically in 0.1 ml 
aliquots of culture fluid using Corinth Ca (Plasmacorinth B) as the complexing dye 
[lci]. A modified biuret procedure was used to determine protein concentrations in 
0.2 ml aliquots of culture fluid [13]. 45Ca was measured in an automatic liquid scintilla- 
tion counter as described previously [21]. 
Calculations.-Results are expressed either as the “%a release, measured as cpm/ 
0.1 ml of the incubation medium at the end of the experiment, or as the ratio of the 
%a release from the treated bone to that from the paired control (T/C ratio). Respon- 
ses were analyzed for significance with a a-tailed t test. 
RESULTS 
Chemically defined media 
Table I shows the effect of parathyroid hormone treatment on embryonic 
bone cultivated in a number of readily-available chemically-defined media. 
Crude parathyroid extract (PTE) failed to stimulate 45Ca release in three 
of the media tested (Eagle Minimal Essential Medium, Trowel1 T-S and 
n’aymouth MB 752/l). With addition of cofactors to the Waymouth medium, 
there was a moderate response to PTE. A further increase in the response to 
PTE was seen with the highly complex medium 1066 containing a crude 
nucleotide fraction (1066, DIFCO). Less PTE effect was seen lvhen a more 
highly purified 1066 preparation (CMRL 1066, GIBCO) was used. When 
an equivalent amount of purified parathyroid hormone (PTH) was substitu- 
ted for the parathyroid extract (PTE), no hormone effect could be detected 
either in CMRL 1066 or in two other complex media (McCoy 5A, NCTC 109). 
A threefold increase in the concentration of purified PTH failed to restore 
a response. 
Serum concentration required to support the PTH effect 
Table II presents results of several experiments designed to determine the 
proportion of serum essential for maintenance of bones in culture and for an 
optimal PTH effect. Medium CMRL 1066 (GIBCO) was supplemented with 
varying quantities of PTX rat serum. Release of 45Ca from the control bones 
was usually enhanced when the medium was supplemented with 5 per cent 
serum. Lower concentrations of serum had no effect on the control response. 
Significant PTH-induced 45Ca release could be elicited in a medium con- 
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0.99 * 0.07 
0.99 * 0.06 
0.99 * 0.06 
1.06 * 0.03 
1.08*0.10 
0.96 + 0.08 - 
575 k 225 815 +200 1.10~0.29 
Values are mean i standard error for 4SCa release and for the treated/control ratios for paired 
bones with and without parathyroid hormone treatment. 
* Value significantly different from 1.00 (p i 0.05). 
** Value significantly different from 1.00 (p 10.01). 
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taining as little as 0.2 per cent serum, and the PTH effect increased with 
increasing serum concentrations up to 2 per cent serum (Fig. 1). The dose- 
response curve obtained with PTH in medium CMKL 1066 with 2 per cent 
serum is shown in Fig. 2. Using Eagle’s Basal Medium the response to PTH 
was poor in 5 per cent serum but maximal with 50 per cent serum (Fig. 1). 
TABLE II. 45Ca release from embryonic bone and the response to parathyroid 
hormone (PTH, 0.4 ,ug/ml). 
Effect of addition of small amounts of serum to CMRL 1066. 
Control T/C ratio 












































0.99 * 0.04 
2.47 + 0.06* * 
2.39 + 0.33 * 
2.31 +0.36* 











345* 37 1.04 kO.04 
653+ 81a 2.40+0.28* 
728F 8Oa 1.12kO.07 
778F156 1.05 +0.04 
89Ok 83 1.85+0.28 
Values are mean + standard error for 45Ca release from the control members of bone pairs and 
for the treated/control ratios for paired bones with and without parathyroid hormone treatment. 
* Values significantly different from 1.00 (p < 0.05). 
** Value significantly different from 1.00 (p ~0.01). 
a %a release significantly greater than with 0 % serum (p c 0.01). 
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%SERUM PTH )Lg/ml 
Fig. 1. Fig. 2. 
Fig. l.--Relationship between serum content of the medium and the response of embryonic h re 
to 0.4 pg/ml ( = 1 U/ml) PTH. The serum was heat-inactivated PTX rat serum. Values are mean + 
standard error for the treated/control ratios for paired bones with and without parathyroid 
hormone treatment. Numbers of hone pairs are in parentheses. 0, CMRL 1066; 0, Eagle’s basal 
medium. 
Fig. 2.-Dose-response curve for PTH-induced %a release in 2 y0 serum. Media were composed 
of heat-inactivated PTX rat serum and CMRL 1066 (GIBCO). Values are mean + standard error 
for the treated/control ratios for paired bones with and without parathyroid hormone treatment. 
Numbers of bone pairs are in parentheses. 
'I- iB1.E 111. 45Ca release from embryonic bone and the response to parathyroid 
hormone (PTH, 0.4 ,ug/ml). 
Effects of addition of serum, serum dialysate, or residual material to the culture medium (CMRL 
1066-GIBCO). 
Additions 
%a release-cpm/O.l ml 
%a release- 
N Control (C) Treated (T) T/C ratio 
None 4 356222 353+ 26 0.99 +0.04 
5 Y0 PTX rat serum 4 394 * 18 928kl73 2.31 iO.36; 
Dialysate 4 392&32 44X&140 1.16&0.01**a 
Residue 4 465&46b 12481117 2.69+0.07** 
Serum was dialyzed 48 hr at 4’C against culture medium; residue was reconstituted with culture 
medium. 
Values are mean + standard error for Wa release and for the treated/control ratios for paired 
bones with and without parathyroid hormone treatment. 
* Value significantly different from 1.00 (p < 0.05). 
* * Value significantly different from 1.00 (p < 0.01). 
a Value significantly less than T/C ratio in medium containing serum or residue (p < 0.01). 
b %a release significantly greater than with 0 % serum (p i 0.05). 
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The serum constituent required to support the PTH ejrect 
The effects of PTH on 45Ca release were compared in media supplemented 
with whole serum, serum dialysate, or the protein residue remaining inside 
the tubing at the termination of the dialysis (Table III). Only the residue 
fraction significantly increased 45Ca release from the control bones. ,111 three 
supplements enhanced the response to PTH; however the effect was minimal 
\vith the tiialysate, suggesting that a protein component was mainly respon- 
sible for the enhanced PTH ef’i’ect. 
Tal3r,E I\‘. Effectiueness of various serum protein fractions in supporting the 
45Ca release elicited by 0.4 ~uglml PTH. 
Exp. 
no. 
Wa release-cpm/O.l ml 
Serum Cont. \ Wa release- 
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243+ 44 477 f178 1.76 *0.26* 
429f 11 674 * 138 1.6t kO.28 
392* 32 842 k 140 2.15 ?0.29* 
616kl71 10.54 _f345 1.79*0.25* 
1201 * 383 1819&505 1.60 +n.13* 
‘laa* it5 753 & 187 
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352f li 
339+ l-1 
390+ 36 357& 23 
609 * 121 
855 _+238 
983 + 109 






1.32 L 0.1 5 .-. 
0.97 t 0.0,1 - 
I .oo j:O.Oti 
0.95 +o.oa 
Values are mean + standard error for Wa release and for the treated/control ratios for paired 
bones with and without parathyroid hormone treatment. 
* Value significantly different from 1.00 (p < 0.05). 
** Value significantly different from 1.00 (p < 0.01). 
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Data from studies comparing the relative effectiveness of several serum 
protein fractions are included in Table I\‘. All of the albumin fractions tested 
could support a PTH effect when the proteins were present at a concentration 
of ‘2.0 mg/ml of medium. PTS rat albumin was the most cf’fective in enhancing 
the 45Ca release in response to PTH; bovine fraction \’ preparations \vere 
% SERUM (OR ALBUMIN EQUIVALENT1 
I;ig. 3.--Comparisons of the capacity of PTX rat serum (S) with thal of the albumin fraction (A) 
to support the response to 0.4 pg/ml PTH. Media were composed of CMRL 1066 (GIBCO) and 
the indicated amount of heat-inactivated serum or the equivalent amount of albumin from the 
same batch of serum. The amount added was based on an estimated 4 g albumin/100 gram rat 
serum. Values are mean & standard error for the treated/control ratios for paired bones with and 
without parathyroid hormone treatment. 0.08 mg/ml albumin was significantly less effective 
than 0.2 96 serum (p c 0.05). The responses in 1 yb serum vs 0.4 mg/ml albumin, in 2.5 y& serum vs 
1 mgjml albumin, and in 5 y0 serum vs 2 mg/ml albumin did not differ significantly (p > 0.05). 
Numbers of bone pairs are in parentheses. 
somewhat less effective; crystalline bovine and human were the least effective 
of the serum albumins tested. Serum alpha, beta and gamma globulin frac- 
tions added in amounts approximating their concentrations in a medium 
containing 5 per cent serum failed to support a PTH response. The data shown 
in Fig. 3 provide further evidence that albumin is responsible for the effect 
of serum. Amounts of albumin equivalent to those contained in 1.0 to 5.0 
per cent serum were as effective as the whole serum in supporting the PTH 
effect. 
Fire other substances were tested for their capacity to support the response 
to PTH (Table 1’). Gelatin has been reported to increase the activity of 
injected PTH, possibly by delaying its absorption [19, ‘241. In tissue culture 
gelatin had no significant effect. Histone, which at low concentrations has 
efrects on mitochondrial function resembling those of parathyroid hormone 
[l 1, was ineffective in tissue culture. A concentration of heparin previously 
shown to potentiate effects of parathyroid hormone on newborn mouse calva- 
ria in culture [lo] was ineffective in the present culture system using embryo- 
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TABLE 1’. The effect of addition of gelatin, heparin, insulin, calf thymus 
histone or oualbumin on the 45Ca release induced by parathyroid hormone 






U or mg/ml N 
Ka release-cpm/O.l ml 
( Wa release- 






Gelatin 2.0 mg/ml 4 777f155 796 & 1.50 1.05 io.04 
Heparin 10 U/ml 4 332 & 23 36Ok 29 1.08 &0.03 
Insulin 1 [:/ml 3 148& 1 153f IO 1.03 +0.03 
Calf thymus 
histone 2.0 mg/ml 4 228& 60 220+ 52 0.98 + 0.04 
Ovalbumin 2.0 mg/ml 4 204f 35 384&114 1.77 *cl31 
Values are mean + standard error for Wa release and for the treated/control ratios for paired 
bones with and without parathyroid hormone treatment. 
nit rat limb bones. Insulin failed to support the PTH effect. Ovalbumin did 
support an enhanced 45Ca release from I’TH-treated bones; however, the 
magnitude of the response was highly variable. 
Effect ofproteins on the control response 
It has been noted above that serum, as well as the non-dialyzable residue 
of serum could increase 45Ca release from bone cultures in the absence of 
added PTH. The effect of 4 mg/ml of several serum proteins on 45Ca release 
from control bones in medium CMRL 1066 is shown in Table VI. Fraction V 
consistently increased 45Ca release, even after a tenfold dilution. The Ca45 
release elicited by the other serum albumin preparations and the globulin 
fractions was variable and less marked. &albumin did not enhance the 
control 45Ca release, nor did it affect the 45Ca releasing properties of the albu- 
min fractions tested when these were added together. 
Since albumin has a large calcium-binding capacity [ 141, it was considered 
to be possible that the increased 45Ca in the medium could have resulted 
from a binding of the medium calcium by albumin, followed by a release of 
calcium from bone to reestablish equilibrium for free calcium. Equilibrium 
dialysis in medium CMRL 1066 with 45Ca added showed a 10 per cent higher 
final 45Ca content in the compartment which contained 4 mg/ml albumin 
(Table VII). 
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TABLE VI. Capacity of serum proteins to increuse calcium release from bone in 
tissue culture medium CMRL 1066 (GIBCO) in the absence of parnthyroid 
hormone. 
Exp. Serum protein 
no. fraction 
45Ca release-cpm/O.l ml 
Cont. - t ‘%a release 
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293 * 10 
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1.40~0.14 1.05 kO.05 
1.49 + 0.23 1.11 iO.06 
1.45*0.12* 
1.65 kO.34 1.08 +_O.Ol 
1.72 kO.44 1.00 +0.02 
1.87&0.21** 0.97kO.06 
1.79+0.16** 
1.24 kO.14 1.05 kO.05 
1.34 i-o.12 0.95 io.04 
1.29 +0.08* 
1.23 & 0.08 1.00 +0.03 
1.00 io.07 1.02 kO.04 
1.12*0.07 
1.16jO.11 1.08+0.11 
1.2‘4*0.08 1.03 io.02 
1.16kO.O5** 0.88kO.09 
1.25f0.06** l.OO&O.ll 
1.24 F0.05* 0.94&0.10 
1.28 jO.18 0.83 +O.OS 
1.00+0.10 1.03 jo.07 
Values are mean + standard error for Ca45 release and for the treated/control ratios for paired 
bones with and without serum proteins in the medium. 
* Value significantly different from 1.00 (p ~0.05). 
** Value significantly different from 1.00 (p i 0.01). 
a Ratio of calcium content in the media with and without protein, measured at the termination 
of the incubation. 
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TARLE 1’11. Equilibrium dialysis study to evaluate the significance of cnlcium 
bindimg for the 45Ca release produced by albumin. 
Conditions: 37”C, 5% CO, in air, CSIKL 1066, 72 hr. 






1~ (1)  
4.0 mg/mP 0 
Final 
%a (cpm/ml) 25,000 2 1,500 (1.10) 
Albumin 4.2 mg/mlb 0 
1 Measured by weight. 
Determined by protein assay. 
Histologic studies 
Examination of the cultivated bones revealed that there was poor cell sur- 
vival in the chemically-defined media and in media supplemented with small 
amounts of protein (less than 1 mg/ml). 1 n media supplemented with 5 per 
cent serum, PTH produced resorption of the bone matrix accompanied by the 
appearance of osteoclasts and large numbers of fibroblasts. Resorption and 
osteoclasts were just as apparent in media containing 2 mg/ml serum albumin 
or ovalbumin as in 5 per cent serum, but the fibroblastic proliferation in 
response to the hormone was not as marked in the albumin-supplemented 
media. These I’TH-induced changes hvere seen in media containing as little 
as 0.4 mg/ml albumin, despite the poor cellularity. No PTH effects were seen 
with 1066 alone. 
DISCUSSION 
Although organ cultures of embryonic bone rudiments can be maintained 
and may even grow in chemically-defined media [3,12, 271, serum has always 
been a constituent of media in studies of the effects of substances which 
enhance bone resorption in vitro [B, 9, 10, 211. A culture medium without 
serum which would support the resorptive response to parathyroid hormone 
was sought because it could provide a better-defined environment for meta- 
bolic studies and might eliminate some of the variability in response en- 
countered with media containing large amounts of serum. None of the eight 
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commercially available media tested was adequate without protein supple- 
ment. Even the most highly enriched media tested (CMRL 1066, McCoy 5A, 
NCTC 109) could not support bone resorption in response to purified PTH. 
Crude parathyroid extract (PTE) stimulated 45Ca release in three media: 
\I’aymouth 752/l plus cofactors, Difco 1066 and CJIRL 1066; however, the 
non-hormonal proteins in the parathyroid extract may have played a role 
in this response. No response could be obtained to a purified parathyroid 
hormone preparation (PTH) in medium CMRL 1066. However, with the 
addition of as little as 0.2 per cent of serum, this medium could support a 
response to PTH. A maximal response could be obtained with 1 to 2 per cent 
serum, in contrast to the 50 per cent concentration of serum required in the 
Eagle Rasal Medium used in previous studies [8, 20-23]. 
Studies of various serum fractions indicated that a partially purified 
albumin fraction supplied the same factor(s) supporting bone resorption as 
did whole serum. The various serum globulin fractions as well as gelatin, 
histone, heparin and insulin were ineffective. The mechanism of the effect of 
albumin is not known. It does not seem likely that the simple provision of 
arnino acids for nutrition is responsible, since the chemically defined media 
contained high concentrations of amino acids, as did the globulin fractions. 
The colloid osmotic effect of albumin could play a role, but this should have 
been obtained with other proteins. A major difference between albumins and 
other proteins lies in their isoelectric point and availability of protons. The 
binding properties of albumins might play a significant role in several ways. 
Albumin can bind considerable quantities of cation [l-l!. However, unless 
the calcium-binding properties of albumin were remarkably altered by 
parathyroid hormone, this could not explain the present results. \Vhile the 
possibility that parathyroid hormone alters ion binding by bovine albumin 
has been suggested on the basis of studies of calcium and magnesium release 
from dead bone [ 11, IS], these studies were done with large amounts of 
crude parathgroid extract, and produced only small increments in ion 
release. The effects we have seen with PTH on living bone do not occur n-ith 
dead bone in a variety of media. 
Albumin, and to a lesser degree, ovalbumin have been shown to bind a 
variety of organic substances, especially anions [17]. Of these, only free 
fatty acid has been examined in our system thus far, and it does not appear 
to be involved. Vitamin A and vitamin D can enhance bone resorption and 
the latter may play a permissive role in the parathyroid response [‘Ll 1. 
However, these substances are bound to globulins as well as to albumin frac- 
tions [2, 31. The preparations used in the present study did not separate pre- 
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albumin from albumin. The role of the pre-albumin should be examined 
further. The effect cannot be ascribed to contamination with parathyroid and 
thyroid hormones, since serum and albumin obtained from parathyroidecto- 
mized rats and serum from thyroparathyroidectomized rats \vere as effective 
as human or bovine serum. Moreover, the effect of serum \vas largely to 
support a parathyroid response rather than to stimulate bone resorption 
directly. 
A number of the substances tested could stimulate some increase in 45Ca 
release in the absence of I’TH. This elfect \\-as not consistently related to their 
ability to support the PTH response. Calcium binding probably does not 
account for the direct albumin effects noted. On the basis of Carr’s analysis 
of calciwl binding by albumin [4], binding of 0.8 to 1.6 mg Ca/g of protein 
~voulti be expected in the present system. This n-oulti amount to only 0.3 ,ug 
of calcium per culture bound by the smallest amount of bovine fraction \ 
\vhich \vas active in the present system (0.4 mg/ml), lvhile the observed in- 
crease in 45Ca release from bone \vas calculated to represent 2 to 3 fig of 
calcium. 
Fell and ‘l\‘eiss [‘i] reported that immunological reactions between the 
serum and the tissue might stimulate bone resorption. They found that this 
phenomenon was inhibited by heating the sera to 60°C. In preliminary 
experiments \ve found that heat inactivation did not abolish the ability of 
serum either to produce control resorption or to support the PTH response, 
and therefore used such heat-inactivated sera subsequently. It is possible 
that some of our earlier observations [al ] of marked differences in effects 
of serum on control resorption could be ascribed to immunologic reactions. 
It is not certain whether the factors responsible for direct stimulation of 
bone resorption and enhancement of I’TH effects in the present study are 
acting as general nutrients or as specific co-factors for bone resorption. The 
histologic observation that the cellularity of cultures containing serum \vas 
better preserved suggests that albumin may simply act as a nutrient or mate- 
rial to prevent dedifferentiation and deterioration of cells in culture, possibly 
by preventing the loss of coating proteins. On the other hand, the present 
culture system is one in which resorption appears to be the ma,jor cellular 
activity so that the appearance of more and better preserved cells could 
result from a specific stimulation of bone resorption. This appears to be the 
case in PTH-stimulated bones. Whatever their nature, non-parathyroid fac- 
tors regulating bone resorption could have important physiological and 
pathological roles, particularly since some control of bone resorption appears 
to persist after the removal of thyroids and parathyroids. 
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SUMMARY 
2. Several chemically-defined media were tested for their capacity to 
support parathyroid hormone-induced 45Ca release from embrvonic bone. 
Sonc was completely satisfactory. 
2. X medium consisting of 2 per cent serum in CMRL 1066 would support 
the parathyroid hormone effect as well as did media containing 50 per cent 
sc’rurn plus 50 per cent CMRL 1066 or 50 per cent Eagle Rasal Medium. 
3. The albumin content of rat serum could be substituted for the Tvhole 
serum without loss of the observed parathyroid hormone eflect. Different 
albumin preparations varied in their capacity to support the response. Serum 
globulins, gelatin, histone, heparin or insulin could not replace serum. 
1. ,Z numher of substances enhanced 45Ca release in the absence of para- 
thyroid hormone. Bovine albumin (fraction V) was the most effective prepa- 
ration tested. 
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